Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway
Phytotherapy Research · 2023
DOI: 10.1002/ptr.7940 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Phytotherapy Research, 2023. Verfasst von Bhagyalakshmi Nair und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Carcinogenesis, Dietary Supplements, Kelch-Like ECH-Associated Protein 1, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Amrita Vishwa Vidyapeetham University.
Abstract (Originalsprache)
Keap1‐Nrf2 is a fundamental signaling cascade known to promote or prevent carcinogenesis. Extensive studies identify the key target of modulatory aspects of Keap1‐Nrf2 signaling against cancer. Nutraceuticals are those dietary agents with many health benefits that have immense potential for cancer chemoprevention. The nutritional supplements known as nutraceuticals are found to be one of the most promising chemoprevention agents. Upon investigating the dual nature of Nrf2, it became clear that, in addition to shielding normal cells from numerous stresses, Nrf2 may also promote the growth of tumors. In the present review, we performed a systematic analysis of the role of 12 different nutraceuticals like curcumin , s ulforaphane , resveratro l, polyunsaturated fatty acids ( PUFA ) from fish oil , lycopene , soybean , kaempferol , allicin , thymoquinone , quercetin , gingerol , and piperine in modulating the Nrf2/Keap1 signaling mechanism. Among these, 12 Generally Recognized As Safe (GRAS) certified nutraceuticals, sulforaphane is the most extensively studied compound in modulating Keap1‐Nrf signaling. Even though there is much evidence at preclinical levels, further high‐quality research is still required to validate the potential role of these nutraceuticals in Keap1‐Nrf2 modulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.
- Department of Chemistry, Sree Narayana College, Kollam, India.
- Department of Chemistry, Sree Narayana College, Chempazhanthy, India.
- Department of Biochemistry, Sree Narayana College, Kollam, India.
ORCID-Profile: Balachandran S Vinod, Gautam Sethi, Lekshmi R Nath
Förderung
- Amrita Vishwa Vidyapeetham University
Zitieren
APA
Nair, B., Adithya, J. K., Chandrababu, G., Lakshmi, P. K., Koshy, J. J., Manoj, S. V., Ambiliraj, D. B., Vinod, B. S., Sethi, G., & Nath, L. R. (2023). Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.7940
Vancouver
Nair B, Adithya JK, Chandrababu G, Lakshmi PK, Koshy JJ, Manoj SV, et al. Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway. Phytotherapy Research. 2023. doi:10.1002/ptr.7940
BibTeX
@article{Nair2023,
author = {Nair, Bhagyalakshmi and Adithya, Jayaprakash K and Chandrababu, Gopika and Lakshmi, P K and Koshy, Joel Joy and Manoj, Sreedharan Vilasini and Ambiliraj, D B and Vinod, Balachandran S and Sethi, Gautam and Nath, Lekshmi R},
title = {Modulation of carcinogenesis with selected GRAS nutraceuticals via Keap1‐Nrf2 signaling pathway},
journal = {Phytotherapy Research},
year = {2023},
doi = {10.1002/ptr.7940}
}
EUVIMED